As far as the re-order issue is concerned...
One aspect of the release that led me to believe that people taking AndroVir would re-order the product, was this sentence:
"During the AndroVir withdrawal period, all these beneficial trends were reversed and approached pre-study values in all but one subject."
To me, this means that for those who took AndroVir and showed positive results, they would most definitley re-order the product in order to continue the "beneficial trends." Don't you think? What this means to me is if for some reason it didn't work for someone, I don't think they would be re-ordering the product anyway and for those who did get encouraging results it seems at this point that they will "have" to continue ordering to maintain the benefits.
Of course this is just my opinion, but it seems reasonable to assume this to me. Another thing, I see that the stock price isn't really reacting much to this news. Could this be because most of the action that we've seen the past couple of days was the anticipation of good news, and now we have it, so those who bought are now just holding, and not buying more? Hmm.
One last point. I think overall this release is definitely a step in the right direction as far as more clear, and to the point communications go. In any case, way to go Paracelsian!!!
-Rob |
